Rudolf Gygax
Directeur/Membre du Conseil chez The Genetics Co., Inc.
Provenance du réseau au premier degré de Rudolf Gygax
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 18 | |
Nextech Invest AG
 Nextech Invest AG Investment ManagersFinance Nextech Invest AG (Nextech) is an independent venture capital firm with headquarters in Zurich, Switzerland. It was founded by Alfred Scheidegger in 1998. Nextech's investors include public pension funds, banks, asset management companies and Swiss and German high-net worth individuals.
12
| Private Company | Investment Managers | 12 |
The Genetics Co., Inc.
 The Genetics Co., Inc. Medical/Nursing ServicesHealth Services The Genetics Company is a privately held drug discovery and development company active in the areas of cancer and neurodegenerative diseases. The company has identified small molecule inhibitors of two proprietary targets with in the Wnt-pathway, which is believed to play a crucial role in colon cancer. It has also identified small molecule inhibitors of BACE (beta-amyloid converting enzyme). In parallel, the company has identified and is in the process of further characterizing a series of novel growth-related drug target candidate genes for exploitation in cancer therapy. Headquartered in Zurich-Schlieren, Switzerland, the company currently has 29 employees. The Genetics Company offers you a range of high quality products to analyze Amyloid beta peptides x-40 and x-42 for basic research but also for pre-clinical and clinical development and in vitro diagnostics (IVD). Its CE-certified ELISA kits are the only clinically validated products for the determination of the Abeta42/40-Ratio in human CSF. These kits enable the early diagnosis of incipient Alzheimer's disease and can be used for patient stratification and monitoring in clinical trials of Alzheimer drug candidates.
3
| Private Company | Medical/Nursing Services | 3 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Rudolf Gygax via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| University of Basel | College/University | Doctorate Degree Corporate Officer/Principal Doctorate Degree Doctorate Degree Director/Board Member Undergraduate Degree Graduate Degree | |
| TRACON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Operating Officer | |
| University of Zurich | College/University | Graduate Degree Doctorate Degree Doctorate Degree | |
| University of St. Gallen | College/University | Masters Business Admin Masters Business Admin | |
| ACINO HOLDING AG | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| Princeton University | College/University | Corporate Officer/Principal Undergraduate Degree | |
| Swiss Federal Institute of Technology | College/University | Doctorate Degree Chief Administrative Officer | |
Biogen MA, Inc.
 Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Biotechnology | Director of Finance/CFO Corporate Officer/Principal | |
Visgenx, Inc.
 Visgenx, Inc. BiotechnologyHealth Technology Visgenx, Inc. engages in the development of therapeutics to protect against the loss of sight from retinal disorders. Its product pipeline includes Intravitreal Decitabine and gene therapy. The company was founded by Santosh J. Vetticaden and Robert Martin Emanuele and is headquartered in San Diego, CA. | Biotechnology | Director/Board Member | |
| University of Münster | College/University | Doctorate Degree | |
Bank Vontobel AG
 Bank Vontobel AG Investment ManagersFinance Bank Vontobel AG (BV), formerly known as Bank J. Vontobel & Co AG, is a Zurich-based private bank. Established in 1924, BV is a wholly-owned subsidiary of Vontobel Holding AG (SW: VONN) and has offices in Geneva, New York, Frankfurt, Milan, Vienna and Luxembourg. The bank is VONN's private banking arm. In 2006 BV acquired the brokerage and corporate finance activities of Lombard Odier Darier Hentsch, which were integrated into their investment banking subsidiary, Vontobel Equity Research. BV specializes in financial consulting, research and wealth management via mutual funds, hedge funds, derivatives and special products for institutions, pension funds, corporates, high net-worth individuals, family offices and private individuals | Investment Managers | Corporate Officer/Principal | |
Lemongrass Communications AG
 Lemongrass Communications AG Miscellaneous Commercial ServicesCommercial Services Lemongrass Communications AG engages in the provision of strategic communications solutions. It specializes in reputation management, board and executive consulting, special situations, corporate branding and positioning, as well as sponsorship and event communications. The company was founded by Karin Rhomberg and Cornelia Schmid on September 21, 2005 and is headquartered in Zurich, Switzerland. | Miscellaneous Commercial Services | Chairman | |
| SWIPRA Services AG | Chief Executive Officer | ||
| ORASCOM DEVELOPMENT HOLDING AG | Homebuilding | Director/Board Member | |
| GRAUBÜNDNER KANTONALBANK | Regional Banks | Director/Board Member | |
Visana AG
 Visana AG Life/Health InsuranceFinance Visana AG engages in the provision of insurance services for private and corporate clients. It offers mandatory basic health, supplementary, property, and accident insurance. The company was founded in 1996 and is headquartered in Bern, Switzerland. | Life/Health Insurance | Director/Board Member | |
Andermatt Swiss Alps AG
 Andermatt Swiss Alps AG HomebuildingConsumer Durables Andermatt Swiss Alps AG engages in the planning, development, implementation, and operation of a holiday resort. It offers restaurants, hotels, shops, fitness and wellness and convention facilities. The company was founded in 2007 and is headquartered in Altdorf, Switzerland. | Homebuilding | Director/Board Member | |
| BAH Management GmbH | Corporate Officer/Principal | ||
| SPEXIS AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
Discovery Technologies Ltd
 Discovery Technologies Ltd Miscellaneous Commercial ServicesCommercial Services Part of Infinity Pharmaceuticals, Inc., Discovery Technologies Ltd is a Swiss company that provides high output screening capabilities, customized assay development/optimization, and chemical libraries. The company is based in Basel, Switzerland. The company was founded by Helmut H. Kessmann. Discovery Technologies was acquired by Discovery Partners International, Inc. on December 31, 2000 for $7.20 million. | Miscellaneous Commercial Services | Founder | |
Graffinity Pharmaceuticals AG
 Graffinity Pharmaceuticals AG Pharmaceuticals: MajorHealth Technology Graffinity Pharmaceuticals AG specializes in chemical genomics pharmaceutical products. Through its fragment based chemical genomics platform, it provides novel small molecules for drug discovery and chemical genomics approaches. The company was founded in 1998 and is headquartered in Heidelberg, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| CUREVAC N.V. | Pharmaceuticals: Major | Director/Board Member | |
T3 Pharmaceuticals AG
 T3 Pharmaceuticals AG BiotechnologyHealth Technology T3 Pharmaceuticals AG provides medicines and treatment for cancer patient. The company was founded in May 2015 by Simon J. Ittig, Christoph A. Kasper, Marlise Amstutz and Helmut H. Kessmann and is headquartered in Basel, Switzerland. | Biotechnology | Founder | |
| Swiss Healthcare Licensing Group | Director/Board Member | ||
| University of Bern | College/University | Doctorate Degree | |
| University of Warwick | College/University | Graduate Degree | |
Eternygen GmbH
 Eternygen GmbH Pharmaceuticals: MajorHealth Technology Eternygen GmbH engages in the research and development of drugs. It develops new drugs for dietary-related metabolic diseases which include obesity, diabetes mellitus and fatty liver. The company was founded by Marco J. Janezic in June 2012 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Chairman | |
| Kyoto University | College/University | Graduate Degree | |
| DOTTIKON ES HOLDING AG | Chemicals: Specialty | Director/Board Member | |
| Rennverein Zürich | Corporate Officer/Principal | ||
| CFO Forum Schweiz | Corporate Officer/Principal | ||
| ONCONETIX, INC. | Pharmaceuticals: Major | Director/Board Member | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
NGN Capital LLC
 NGN Capital LLC Investment ManagersFinance NGN Capital LLC (NGN Capital) is a venture capital firm founded in 2003 by Kenneth S. Abramowitz and William J. Gedale. The firm is headquartered in New York. | Investment Managers | Founder | |
Viopas Venture Consulting GmbH
 Viopas Venture Consulting GmbH Investment ManagersFinance Viopas Venture Consulting GmbH (Viopas Venture Consulting) is a venture capital firm founded in 2016 by Simon Jules Nebel. The firm is headquartered in Zürich, Switzerland. | Investment Managers | Corporate Officer/Principal | |
| University of Bonn | College/University | Doctorate Degree | |
Javelin Pharmaceuticals, Inc.
 Javelin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Javelin Pharmaceuticals, Inc. develops pharmaceutical drugs. It is a specialty pharmaceutical company that applies innovative proprietary technologies to develop new drugs and improved formulations of existing drugs that target current unmet and underserved medical market. The company's product candidates address the acute moderate-to-severe pain medication market segment. It has three late stage product candidates in development: Dyloject (diclofenac sodium, injectable), Rylomine (intranasal morphine) and PMI-150 (intranasal ketamine). The company was founded on February 23, 1998 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
Kika Medical International Co.
 Kika Medical International Co. Packaged SoftwareTechnology Services KIKA helps the world's most innovative biopharmaceutical and medical device organizations use advanced EDC solutions to bring much-needed medical solutions to market faster. KIKA's Veracity™ is the leading-edge Web-based clinical trial software platform that delivers Clinical Asset Management™ for any size clinical trial. Veracity is customized to meet study needs precisely. It provides unmatched flexibility and customization with advanced EDC including images and online adjudication. Veracity is backed by the industry's most reliable IT infrastructure and a world class Professional Services organization | Packaged Software | Director/Board Member | |
Kirax Corp.
 Kirax Corp. Pharmaceuticals: MajorHealth Technology Kirax Corp. researches, develops, manufactures and distributes pharmaceutical products. The firm provides specialty care therapies to treat oncology, pain, inflammation, acute, and supportive care areas of unmet medical need. The company was founded by Mark E. Pruzanski, David M. Tanen and Edmundo Muniz in 2005 and is headquartered in Bonita Springs, FL. | Pharmaceuticals: Major | Director/Board Member |
Statistiques
Internationale
| Suisse | 26 |
| Etats-Unis | 12 |
| Allemagne | 10 |
| Pays-Bas | 3 |
| Royaume-Uni | 2 |
Sectorielle
| Health Technology | 19 |
| Consumer Services | 11 |
| Finance | 9 |
| Commercial Services | 5 |
| Consumer Durables | 3 |
Opérationnelle
| Director/Board Member | 148 |
| Corporate Officer/Principal | 61 |
| Chairman | 27 |
| Independent Dir/Board Member | 23 |
| Chief Executive Officer | 18 |
Relations les plus connectées
| Insiders | |
|---|---|
| Hans-Peter Hasler | 28 |
| Michael Lytton | 24 |
| Bernd Seizinger | 23 |
| Thomas Lips | 23 |
| Timothy James Rink | 23 |
| Alfred Scheidegger | 20 |
| Georg Nebgen | 18 |
| Thilo Schroeder | 18 |
| Klaus Schollmeier | 17 |
| Barbara Anna Heller | 17 |
| Martin Gertsch | 14 |
| Hans-Beat Gürtler | 13 |
| Kimi Iguchi | 10 |
| Myoung-Ok Kwon | 10 |
| Thomas Meier | 9 |
- Bourse
- Insiders
- Rudolf Gygax
- Connexions Sociétés
